Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer.
Sci Adv. 2021 May 19;7(21):eabf2567. doi: 10.1126/sciadv.abf2567. Print 2021 May.
Sci Adv. 2021.
PMID: 34138730
Free PMC article.